Literature DB >> 17229678

Nephrogenic diabetes insipidus in mice caused by deleting COOH-terminal tail of aquaporin-2.

Peijun P Shi1, Xiao R Cao, Jing Qu, Ken A Volk, Patricia Kirby, Roger A Williamson, John B Stokes, Baoli Yang.   

Abstract

In mammals, the hormonal regulation of water homeostasis is mediated by the aquaporin-2 water channel (Aqp2) of the collecting duct (CD). Vasopressin induces redistribution of Aqp2 from intracellular vesicles to the apical membrane of CD principal cells, accompanied by increased water permeability. Mutations of AQP2 gene in humans cause both recessive and dominant nephrogenic diabetes insipidus (NDI), a disease in which the kidney is unable to concentrate urine in response to vasopressin. In this study, we generated a line of mice with the distal COOH-terminal tail of the Aqp2 deleted (Aqp2(Delta230)), including the protein kinase A phosphorylation site (S256), but still retaining the putative apical localization signal (221-229) at the COOH-terminal. Mice heterozygous for the truncation appear normal. Homozygotes are viable to adulthood, with reduced urine concentrating capacity, increased urine output, decreased urine osmolality, and increased daily water consumption. Desmopressin increased urine osmolality in wild-type mice but had no effect on Aqp2(Delta230/Delta230) mice. Kidneys from affected mice showed CD and pelvis dilatation and papillary atrophy. By immunohistochemical and immunoblot analyses using antibody against the NH(2)-terminal region of the protein Aqp2(Delta230/Delta230) mice had a markedly reduced protein abundance. Expression of the truncated protein in MDCK cells was consistent with a small amount of functional expression but no stimulation. Thus we have generated a mouse model of NDI that may be useful in studying the physiology and potential therapy of this disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17229678      PMCID: PMC2818797          DOI: 10.1152/ajprenal.00308.2006

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  35 in total

Review 1.  Minireview: aquaporin 2 trafficking.

Authors:  Giovanna Valenti; Giuseppe Procino; Grazia Tamma; Monica Carmosino; Maria Svelto
Journal:  Endocrinology       Date:  2005-09-08       Impact factor: 4.736

Review 2.  Nephrogenic diabetes insipidus.

Authors:  Jeff M Sands; Daniel G Bichet
Journal:  Ann Intern Med       Date:  2006-02-07       Impact factor: 25.391

Review 3.  Trafficking mechanism of water channel aquaporin-2.

Authors:  Yumi Noda; Sei Sasaki
Journal:  Biol Cell       Date:  2005-12       Impact factor: 4.458

Review 4.  Molecular biology of hereditary diabetes insipidus.

Authors:  T Mary Fujiwara; Daniel G Bichet
Journal:  J Am Soc Nephrol       Date:  2005-08-10       Impact factor: 10.121

Review 5.  Molecular mechanisms and drug development in aquaporin water channel diseases: molecular mechanism of water channel aquaporin-2 trafficking.

Authors:  Yumi Noda; Sei Sasaki
Journal:  J Pharmacol Sci       Date:  2004-11-12       Impact factor: 3.337

6.  Lack of arginine vasopressin-induced phosphorylation of aquaporin-2 mutant AQP2-R254L explains dominant nephrogenic diabetes insipidus.

Authors:  Fabrizio de Mattia; Paul J M Savelkoul; Erik-Jan Kamsteeg; Irene B M Konings; Peter van der Sluijs; Rudolf Mallmann; Alexander Oksche; Peter M T Deen
Journal:  J Am Soc Nephrol       Date:  2005-08-24       Impact factor: 10.121

7.  Disruption of the beta subunit of the epithelial Na+ channel in mice: hyperkalemia and neonatal death associated with a pseudohypoaldosteronism phenotype.

Authors:  F J McDonald; B Yang; R F Hrstka; H A Drummond; D E Tarr; P B McCray; J B Stokes; M J Welsh; R A Williamson
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-16       Impact factor: 11.205

8.  Arginine vasopressin stimulates phosphorylation of aquaporin-2 in rat renal tissue.

Authors:  G Nishimoto; M Zelenina; D Li; M Yasui; A Aperia; S Nielsen; A C Nairn
Journal:  Am J Physiol       Date:  1999-02

9.  An aquaporin-2 water channel mutant which causes autosomal dominant nephrogenic diabetes insipidus is retained in the Golgi complex.

Authors:  S M Mulders; D G Bichet; J P Rijss; E J Kamsteeg; M F Arthus; M Lonergan; M Fujiwara; K Morgan; R Leijendekker; P van der Sluijs; C H van Os; P M Deen
Journal:  J Clin Invest       Date:  1998-07-01       Impact factor: 14.808

Review 10.  Aquaporin-2 water channel mutations causing nephrogenic diabetes insipidus.

Authors:  C H van Os; P M Deen
Journal:  Proc Assoc Am Physicians       Date:  1998 Sep-Oct
View more
  12 in total

Review 1.  Regulation of transport in the connecting tubule and cortical collecting duct.

Authors:  Alexander Staruschenko
Journal:  Compr Physiol       Date:  2012-04       Impact factor: 9.090

2.  Urinary bladder hypertrophy characteristic of male ROMK Bartter's mice does not occur in female mice.

Authors:  Jun-Mo Kim; Shuhua Xu; Xiaoyun Guo; Haiyan Hu; Ke Dong; Tong Wang
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2017-11-01       Impact factor: 3.619

3.  Central diabetes insipidus associated with impaired renal aquaporin-1 expression in mice lacking liver X receptor β.

Authors:  Chiara Gabbi; Xiaomu Kong; Hitoshi Suzuki; Hyun-Jin Kim; Min Gao; Xiao Jia; Hideo Ohnishi; Yoichi Ueta; Margaret Warner; Youfei Guan; Jan-Åke Gustafsson
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-07       Impact factor: 11.205

4.  Hsp90 inhibitor partially corrects nephrogenic diabetes insipidus in a conditional knock-in mouse model of aquaporin-2 mutation.

Authors:  Baoxue Yang; Dan Zhao; A S Verkman
Journal:  FASEB J       Date:  2008-10-14       Impact factor: 5.191

5.  Genetic ablation of aquaporin-2 in the mouse connecting tubules results in defective renal water handling.

Authors:  Marleen L A Kortenoeven; Nis Borbye Pedersen; R Lance Miller; Aleksandra Rojek; Robert A Fenton
Journal:  J Physiol       Date:  2013-01-28       Impact factor: 5.182

6.  Serine 269 phosphorylated aquaporin-2 is targeted to the apical membrane of collecting duct principal cells.

Authors:  Hanne B Moeller; Mark A Knepper; Robert A Fenton
Journal:  Kidney Int       Date:  2008-10-08       Impact factor: 10.612

Review 7.  Nephrogenic diabetes insipidus: essential insights into the molecular background and potential therapies for treatment.

Authors:  Hanne B Moeller; Søren Rittig; Robert A Fenton
Journal:  Endocr Rev       Date:  2013-01-29       Impact factor: 19.871

8.  A selective EP4 PGE2 receptor agonist alleviates disease in a new mouse model of X-linked nephrogenic diabetes insipidus.

Authors:  Jian Hua Li; Chung-Lin Chou; Bo Li; Oksana Gavrilova; Christoph Eisner; Jürgen Schnermann; Stasia A Anderson; Chu-Xia Deng; Mark A Knepper; Jürgen Wess
Journal:  J Clin Invest       Date:  2009-10       Impact factor: 14.808

Review 9.  The Trafficking of the Water Channel Aquaporin-2 in Renal Principal Cells-a Potential Target for Pharmacological Intervention in Cardiovascular Diseases.

Authors:  Tanja Vukićević; Maike Schulz; Dörte Faust; Enno Klussmann
Journal:  Front Pharmacol       Date:  2016-02-11       Impact factor: 5.810

Review 10.  Hereditary Nephrogenic Diabetes Insipidus: Pathophysiology and Possible Treatment. An Update.

Authors:  Serena Milano; Monica Carmosino; Andrea Gerbino; Maria Svelto; Giuseppe Procino
Journal:  Int J Mol Sci       Date:  2017-11-10       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.